In the present study, we aimed to disentangle the impact of IL-1β in a Sh3bp2 KI mouse model of cherubism and determine whether IL-1β could be a novel therapeutic target to rescue the bone phenotype. This evidence concerns the gene SH3BP2 and cherubism.